Testicular non-seminomatous germ cell cancer
MONDO:0003403A classification of testicular cancers that arise in specialized sex cells called germ cells. Nonseminomas include embryonal carcinoma, teratoma, choriocarcinoma, and yolk sac tumor.
Also known as: malignant non-seminomatous germ cell cancer of testis, malignant non-seminomatous germ cell cancer of the testis, malignant non-seminomatous germ cell neoplasm of testis, malignant non-seminomatous germ cell neoplasm of the testis, malignant non-seminomatous germ cell tumor of testis, malignant non-seminomatous germ cell tumor of the testis, malignant non-seminomatous germ cell tumour of testis, malignant non-seminomatous germ cell tumour of the testis
2738 clinical trials for this condition and its sub-types, 3 tagged with Testicular non-seminomatous germ cell cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Testicular non-seminomatous germ cell cancer
-
Testicular embryonal carcinoma 1 trial · 2 incl. sub-types
2 sub-types
- Intratubular embryonal carcinoma 1 trial
- Childhood embryonal testis carcinoma 0 trials
-
Choriocarcinoma of testis 1 trial
2 sub-types
- Childhood testicular choriocarcinoma 0 trials
- Testicular monophasic choriocarcinoma 0 trials
-
Testicular yolk sac tumor 1 trial
10 sub-types
- Enteric pattern testicular yolk sac tumor 0 trials
- Polyvesicular vitelline pattern testicular yolk sac tumor 0 trials
- Reticular pattern testicular yolk sac tumor 0 trials
- Testicular yolk sac tumor, endodermal sinus pattern 0 trials
- Testicular yolk sac tumor, glandular-alveolar pattern 0 trials
- Testicular yolk sac tumor, hepatoid pattern 0 trials
- Testicular yolk sac tumor, macrocystic pattern 0 trials
- Testicular yolk sac tumor, myxomatous pattern 0 trials
- Testicular yolk sac tumor, papillary pattern 0 trials
- Testicular yolk sac tumor, solid pattern 0 trials
-
Major trial tests gentler chemo for germ cell tumors
Disease control Recruiting nowThis phase 3 trial studies two approaches for germ cell tumors. For low-risk patients whose tumor has been removed, doctors will monitor them closely instead of giving chemotherapy. For standard-risk patients whose cancer has spread, the trial compares two chemotherapy drugs—carb…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a simple injection save your hearing during cancer treatment?
Symptom relief Recruiting nowThis early-stage trial tests whether adding Pedmark to standard cisplatin chemotherapy can prevent hearing loss in men with metastatic testicular cancer. About 80% of patients currently develop hearing damage from cisplatin. Pedmark works by neutralizing harmful molecules that ca…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC